Phase I study of LY2127399, a human anti-BAFF antibody, and bortezomib in patients with previously treated multiple myeloma.
N. S. Raje
No relevant relationships to disclose
R. J. Hohl
Research Funding - Lilly
E. A. Faber
Consultant or Advisory Role - Millennium
P. G. G. Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis
A. Forero-Torres
Research Funding - Lilly
G. J. Schiller
Research Funding - Lilly
A. D. Cohen
Consultant or Advisory Role - Celgene; Millennium; Onyx
Honoraria - Celgene
S. P. Carpenter
Employment or Leadership Position - Lilly
D. Cronier
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
M. Pashkevich
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
J. Wooldridge
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
K. C. Anderson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx